Home › Companies › Foghorn Therapeutics Inc. › 2025-2026
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and Foghorn Therapeutics Inc.’s Form 8-K, filed June 24, 2026 (Item 5.07 on EDGAR). Page generated November 20, 2026.
Meeting of June 24, 2026: 3 items on Foghorn Therapeutics Inc.’s Form 8-K, filed June 24, 2026: 3 elected.
Significant dissent: 1 director (23.8% against).
Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided
Proxy season: 2025-2026
Explore Foghorn Therapeutics Inc. in the interactive database Compare manager voting policies
These tallies are Foghorn Therapeutics Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 24, 2026 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Douglas Cole, M.D. | 35,118,798 | 10,987,092 | 5,562 | -- | 5,597,444 | 76% | Elected | — |
| Elect Director: Simba Gill, Ph.D. | 45,956,872 | 151,145 | 3,435 | -- | 5,597,444 | 99.7% | Elected | — |
| Elect Director: B. Lynne Parshall | 44,412,258 | 1,695,530 | 3,664 | -- | 5,597,444 | 96% | Elected | — |
Source: Foghorn Therapeutics Inc., Form 8-K, filed with the SEC on June 24, 2026 — read the filing on EDGAR.
See voting trends for Health Care companies, 2025-2026: shareholder support by sector and by company size.
116 asset managers disclosed a vote on at least one Foghorn Therapeutics Inc. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of Foghorn Therapeutics Inc.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 4 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
Description as filed by funds: Elect Class III directors each for a three-year term: B. Lynne Parshall
Foghorn Therapeutics Inc.’s own tally for this item (“Elect Director: B. Lynne Parshall”): 44,412,258 for, 1,695,530 against, per its Form 8-K filed June 24, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The stockholders of the Company elected each of the following director nominees to serve until the 2029 Annual Meeting of Stockholders and until his or her successor is duly elected and qualified or until his or her earlier death, resignation or removal.”
Support: 96% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 37 asset managers below reported 7,223,735 for, 242,154 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 3,935,922 | 0 | 0 | 0 | For |
| Vanguard | 1,729,823 | 4,597 | 0 | 0 | For |
| BlackRock | 1,169,164 | 0 | 0 | 0 | For |
| Charles Schwab | 103,502 | 0 | 0 | 0 | For |
| Equitable | 55,881 | 19,140 | 0 | 0 | Mixed |
| BRIDGEWAY FUNDS INC | 0 | 68,000 | 0 | 0 | Against |
| TIAA | 0 | 49,073 | 0 | 0 | Against |
| QUANTITATIVE MASTER SERIES LLC | 43,623 | 0 | 0 | 0 | For |
| Nationwide | 7,437 | 32,624 | 0 | 0 | Mixed |
| Columbia Threadneedle | 28,105 | 0 | 0 | 0 | For |
| Goldman Sachs | 27,548 | 0 | 0 | 0 | For |
| Northern Trust | 25,133 | 0 | 0 | 0 | For |
| Lincoln Financial | 20,000 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 0 | 16,607 | 0 | 0 | Against |
| Global X | 15,048 | 0 | 0 | 0 | For |
| Pacific Life | 13,626 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 0 | 13,584 | 0 | 0 | Against |
| PACE SELECT ADVISORS TRUST | 0 | 12,480 | 0 | 0 | Against |
| State Street | 11,060 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 10,778 | 0 | 0 | 0 | For |
| Invesco | 8,130 | 0 | 0 | 0 | For |
| ProShares | 0 | 7,658 | 0 | 0 | Against |
| Voya | 6,490 | 0 | 0 | 0 | For |
| DWS | 0 | 5,062 | 0 | 0 | Against |
| T. Rowe Price | 4,268 | 0 | 0 | 0 | For |
Showing the 25 largest of 37 asset managers. All 37 are in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
99.7% Majority: yes · of votes cast
Description as filed by funds: Elect Class III directors each for a three-year term: Balkrishan (Simba) Gill, Ph.D.
Foghorn Therapeutics Inc.’s own tally for this item (“Elect Director: Simba Gill, Ph.D.”): 45,956,872 for, 151,145 against, per its Form 8-K filed June 24, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The stockholders of the Company elected each of the following director nominees to serve until the 2029 Annual Meeting of Stockholders and until his or her successor is duly elected and qualified or until his or her earlier death, resignation or removal.”
Support: 99.7% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 37 asset managers below reported 7,443,488 for, 22,402 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 3,935,922 | 0 | 0 | 0 | For |
| Vanguard | 1,731,339 | 3,082 | 0 | 0 | For |
| BlackRock | 1,169,164 | 0 | 0 | 0 | For |
| Charles Schwab | 103,502 | 0 | 0 | 0 | For |
| Equitable | 55,881 | 19,140 | 0 | 0 | Mixed |
| BRIDGEWAY FUNDS INC | 68,000 | 0 | 0 | 0 | For |
| TIAA | 49,073 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 43,623 | 0 | 0 | 0 | For |
| Nationwide | 40,061 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 28,105 | 0 | 0 | 0 | For |
| Goldman Sachs | 27,548 | 0 | 0 | 0 | For |
| Northern Trust | 25,133 | 0 | 0 | 0 | For |
| Lincoln Financial | 20,000 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 16,607 | 0 | 0 | 0 | For |
| Global X | 15,048 | 0 | 0 | 0 | For |
| Pacific Life | 13,626 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 13,584 | 0 | 0 | 0 | For |
| PACE SELECT ADVISORS TRUST | 12,480 | 0 | 0 | 0 | For |
| State Street | 11,060 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 10,778 | 0 | 0 | 0 | For |
| Invesco | 8,130 | 0 | 0 | 0 | For |
| ProShares | 7,658 | 0 | 0 | 0 | For |
| Voya | 6,490 | 0 | 0 | 0 | For |
| DWS | 5,062 | 0 | 0 | 0 | For |
| T. Rowe Price | 4,268 | 0 | 0 | 0 | For |
Showing the 25 largest of 37 asset managers. All 37 are in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
76% Majority: yes · of votes cast
Description as filed by funds: Elect Class III directors each for a three-year term: Douglas Cole, M.D.
Foghorn Therapeutics Inc.’s own tally for this item (“Elect Director: Douglas Cole, M.D.”): 35,118,798 for, 10,987,092 against, per its Form 8-K filed June 24, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The stockholders of the Company elected each of the following director nominees to serve until the 2029 Annual Meeting of Stockholders and until his or her successor is duly elected and qualified or until his or her earlier death, resignation or removal.”
Support: 76% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 37 asset managers below reported 2,491,791 for, 4,974,098 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 722,040 | 3,213,882 | 0 | 0 | Mixed |
| Vanguard | 1,729,805 | 4,615 | 0 | 0 | For |
| BlackRock | 0 | 1,169,164 | 0 | 0 | Against |
| Charles Schwab | 0 | 103,502 | 0 | 0 | Against |
| Equitable | 0 | 75,021 | 0 | 0 | Against |
| BRIDGEWAY FUNDS INC | 0 | 68,000 | 0 | 0 | Against |
| TIAA | 0 | 49,073 | 0 | 0 | Against |
| QUANTITATIVE MASTER SERIES LLC | 0 | 43,623 | 0 | 0 | Against |
| Nationwide | 0 | 40,061 | 0 | 0 | Against |
| Columbia Threadneedle | 0 | 28,105 | 0 | 0 | Against |
| Goldman Sachs | 27,548 | 0 | 0 | 0 | For |
| Northern Trust | 0 | 25,133 | 0 | 0 | Against |
| Lincoln Financial | 0 | 20,000 | 0 | 0 | Against |
| AIG/SunAmerica | 0 | 16,607 | 0 | 0 | Against |
| Global X | 0 | 15,048 | 0 | 0 | Against |
| Pacific Life | 0 | 13,626 | 0 | 0 | Against |
| CLEARWATER INVESTMENT TRUST | 0 | 13,584 | 0 | 0 | Against |
| PACE SELECT ADVISORS TRUST | 0 | 12,480 | 0 | 0 | Against |
| State Street | 0 | 11,060 | 0 | 0 | Against |
| Bridge Builder Trust | 0 | 10,778 | 0 | 0 | Against |
| Invesco | 8,130 | 0 | 0 | 0 | For |
| ProShares | 0 | 7,658 | 0 | 0 | Against |
| Voya | 0 | 6,490 | 0 | 0 | Against |
| DWS | 0 | 5,062 | 0 | 0 | Against |
| T. Rowe Price | 4,268 | 0 | 0 | 0 | For |
Showing the 25 largest of 37 asset managers. All 37 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
98% Fund and manager reports combined; may count the same shares twice · no official result
Description as filed by funds: TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF FOGHORN'S NAMED EXECUTIVE OFFICERS.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 3,935,922 | 0 | 0 | 0 | For |
| Vanguard | 1,734,420 | 1 | 0 | 0 | For |
| BlackRock | 1,169,164 | 0 | 0 | 0 | For |
| Charles Schwab | 103,502 | 0 | 0 | 0 | For |
| Equitable | 75,021 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 0 | 68,000 | 0 | 0 | Against |
| TIAA | 49,073 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 43,623 | 0 | 0 | 0 | For |
| Nationwide | 40,061 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 28,105 | 0 | 0 | 0 | For |
| Goldman Sachs | 27,548 | 0 | 0 | 0 | For |
| Northern Trust | 25,133 | 0 | 0 | 0 | For |
| Lincoln Financial | 20,000 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 16,607 | 0 | 0 | 0 | For |
| Global X | 15,048 | 0 | 0 | 0 | For |
| Pacific Life | 13,626 | 0 | 0 | 0 | For |
| PACE SELECT ADVISORS TRUST | 12,480 | 0 | 0 | 0 | For |
| State Street | 11,060 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 10,778 | 0 | 0 | 0 | For |
| Invesco | 0 | 8,130 | 0 | 0 | Against |
| ProShares | 7,658 | 0 | 0 | 0 | For |
| Voya | 6,490 | 0 | 0 | 0 | For |
| DWS | 5,062 | 0 | 0 | 0 | For |
| T. Rowe Price | 4,268 | 0 | 0 | 0 | For |
| SEI | 4,200 | 0 | 0 | 0 | For |
Fund voting reports, all 36 managers: 7,376,175 for, 76,131 against. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 5,938,877 | 0 | 0 | 0 | For |
| BVF INC/IL | 5,842,000 | 0 | 0 | 0 | For |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 4,394,367 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 849,481 | 0 | 0 | 0 | For |
| BlackRock | 821,636 | 890 | 0 | 0 | For |
| Siren, L.L.C. | 712,794 | 0 | 0 | 0 | For |
| State Street | 596,307 | 702 | 0 | 0 | For |
| Candriam S.C.A. | 0 | 313,765 | 0 | 0 | Against |
| AMERIPRISE FINANCIAL INC | 255,755 | 0 | 0 | 0 | For |
| Vanguard | 255,121 | 0 | 0 | 0 | For |
| Northern Trust | 240,011 | 0 | 0 | 0 | For |
| SCS Capital Management LLC | 113,736 | 0 | 0 | 0 | For |
| DAFNA Capital Management LLC | 111,859 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 109,846 | 0 | 0 | 0 | For |
| Charles Schwab | 103,524 | 0 | 0 | 0 | For |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 92,932 | 0 | 0 | 0 | For |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0 | 74,600 | 0 | 0 | Against |
| STATE OF WISCONSIN INVESTMENT BOARD | 66,563 | 0 | 0 | 0 | For |
| Nuveen | 50,394 | 0 | 0 | 0 | For |
| T. Rowe Price | 48,956 | 0 | 0 | 0 | For |
| Renaissance | 43,053 | 0 | 0 | 0 | For |
| Goldman Sachs | 39,660 | 0 | 0 | 0 | For |
| ACADIAN ASSET MANAGEMENT LLC | 28,813 | 0 | 0 | 0 | For |
| AllianceBernstein | 26,660 | 0 | 0 | 0 | For |
| CANADA PENSION PLAN INVESTMENT BOARD | 25,100 | 0 | 0 | 0 | For |
Institutional-manager reports, all 91 managers: 21,010,428 for, 413,094 against, 200 not voted, 7,843 1 year. Showing the 25 largest; every one is in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
99% Fund and manager reports combined; may count the same shares twice · no official result
Description as filed by funds: TO APPROVE, ON AN ADVISORY BASIS, THE FREQUENCY OF FUTURE ADVISORY VOTES ON THE COMPENSATION OF FOGHORN'S NAMED EXECUTIVE OFFICERS.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 0 | 0 | 0 | 0 | -- |
| Vanguard | 0 | 0 | 0 | 0 | -- |
| BlackRock | 0 | 0 | 0 | 0 | -- |
| Charles Schwab | 0 | 0 | 0 | 0 | -- |
| Equitable | 0 | 0 | 0 | 0 | -- |
| BRIDGEWAY FUNDS INC | 0 | 0 | 0 | 0 | -- |
| TIAA | 0 | 0 | 0 | 0 | -- |
| QUANTITATIVE MASTER SERIES LLC | 0 | 0 | 0 | 0 | -- |
| Nationwide | 0 | 0 | 0 | 0 | -- |
| Columbia Threadneedle | 0 | 0 | 0 | 0 | -- |
| Goldman Sachs | 0 | 0 | 0 | 0 | -- |
| Northern Trust | 0 | 0 | 0 | 0 | -- |
| Lincoln Financial | 0 | 0 | 0 | 0 | -- |
| AIG/SunAmerica | 0 | 0 | 0 | 0 | -- |
| Global X | 0 | 0 | 0 | 0 | -- |
| Pacific Life | 0 | 0 | 0 | 0 | -- |
| PACE SELECT ADVISORS TRUST | 0 | 0 | 0 | 0 | -- |
| State Street | 0 | 0 | 0 | 0 | -- |
| Bridge Builder Trust | 0 | 0 | 0 | 0 | -- |
| Invesco | 0 | 0 | 0 | 0 | -- |
| ProShares | 0 | 0 | 0 | 0 | -- |
| Voya | 0 | 0 | 0 | 0 | -- |
| DWS | 0 | 0 | 0 | 0 | -- |
| T. Rowe Price | 0 | 0 | 0 | 0 | -- |
| SEI | 0 | 0 | 0 | 0 | -- |
Fund voting reports, all 36 managers: 2,600 for, 7,449,642 1 year, 64 unknown. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 0 | 0 | 0 | 0 | -- |
| BVF INC/IL | 0 | 0 | 0 | 0 | -- |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 0 | 0 | 0 | 0 | -- |
| GEODE CAPITAL MANAGEMENT, LLC | 0 | 0 | 0 | 0 | -- |
| BlackRock | 0 | 0 | 0 | 0 | -- |
| Siren, L.L.C. | 0 | 0 | 0 | 0 | -- |
| State Street | 0 | 0 | 0 | 0 | -- |
| Candriam S.C.A. | 0 | 0 | 0 | 0 | -- |
| AMERIPRISE FINANCIAL INC | 0 | 0 | 0 | 0 | -- |
| Vanguard | 0 | 0 | 0 | 0 | -- |
| Northern Trust | 0 | 0 | 0 | 0 | -- |
| SCS Capital Management LLC | 0 | 0 | 0 | 0 | -- |
| DAFNA Capital Management LLC | 0 | 0 | 0 | 0 | -- |
| MELLON INVESTMENTS Corp | 0 | 0 | 0 | 0 | -- |
| Charles Schwab | 0 | 0 | 0 | 0 | -- |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 0 | 0 | 0 | 0 | -- |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0 | 0 | 0 | 0 | -- |
| STATE OF WISCONSIN INVESTMENT BOARD | 0 | 0 | 0 | 0 | -- |
| Nuveen | 0 | 0 | 0 | 0 | -- |
| T. Rowe Price | 0 | 0 | 0 | 0 | -- |
| Renaissance | 0 | 0 | 0 | 0 | -- |
| Goldman Sachs | 0 | 0 | 0 | 0 | -- |
| ACADIAN ASSET MANAGEMENT LLC | 0 | 0 | 0 | 0 | -- |
| AllianceBernstein | 0 | 0 | 0 | 0 | -- |
| CANADA PENSION PLAN INVESTMENT BOARD | 0 | 0 | 0 | 0 | -- |
Institutional-manager reports, all 91 managers: 7,714 for, 140 against, 200 not voted, 21,423,511 1 year. Showing the 25 largest; every one is in the interactive database (link above).
100% of fund votes cast · no official result
Description as filed by funds: TO RATIFY THE SELECTION OF DELOITTE & TOUCHE LLP AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE COMPANY FOR THE FISCAL YEAR ENDING DECEMBER 31, 2026.
The 36 asset managers below reported 7,452,306 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 3,935,922 | 0 | 0 | 0 | For |
| Vanguard | 1,734,421 | 0 | 0 | 0 | For |
| BlackRock | 1,169,164 | 0 | 0 | 0 | For |
| Charles Schwab | 103,502 | 0 | 0 | 0 | For |
| Equitable | 75,021 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 68,000 | 0 | 0 | 0 | For |
| TIAA | 49,073 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 43,623 | 0 | 0 | 0 | For |
| Nationwide | 40,061 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 28,105 | 0 | 0 | 0 | For |
| Goldman Sachs | 27,548 | 0 | 0 | 0 | For |
| Northern Trust | 25,133 | 0 | 0 | 0 | For |
| Lincoln Financial | 20,000 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 16,607 | 0 | 0 | 0 | For |
| Global X | 15,048 | 0 | 0 | 0 | For |
| Pacific Life | 13,626 | 0 | 0 | 0 | For |
| PACE SELECT ADVISORS TRUST | 12,480 | 0 | 0 | 0 | For |
| State Street | 11,060 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 10,778 | 0 | 0 | 0 | For |
| Invesco | 8,130 | 0 | 0 | 0 | For |
| ProShares | 7,658 | 0 | 0 | 0 | For |
| Voya | 6,490 | 0 | 0 | 0 | For |
| DWS | 5,062 | 0 | 0 | 0 | For |
| T. Rowe Price | 4,268 | 0 | 0 | 0 | For |
| SEI | 4,200 | 0 | 0 | 0 | For |
Showing the 25 largest of 36 asset managers. All 36 are in the interactive database (link above).
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 58,713,922 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Fidelity | 6.70% |
| 2 | Vanguard | 2.95% |
| 3 | BlackRock | 1.99% |
| 4 | Charles Schwab | 0.18% |
| 5 | Equitable | 0.13% |
| 6 | BRIDGEWAY FUNDS INC | 0.12% |
| 7 | TIAA | 0.08% |
| 8 | QUANTITATIVE MASTER SERIES LLC | 0.07% |
| 9 | Nationwide | 0.07% |
| 10 | Columbia Threadneedle | 0.05% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Fidelity | 10.11% |
| 2 | BVF INC/IL | 9.95% |
| 3 | DEERFIELD MANAGEMENT COMPANY, L.P. | 7.48% |
| 4 | GEODE CAPITAL MANAGEMENT, LLC | 1.45% |
| 5 | BlackRock | 1.40% |
| 6 | Siren, L.L.C. | 1.21% |
| 7 | State Street | 1.02% |
| 8 | Candriam S.C.A. | 0.53% |
| 9 | AMERIPRISE FINANCIAL INC | 0.44% |
| 10 | Vanguard | 0.43% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.
| Holder | Shares | % outstanding | Source, as of |
|---|---|---|---|
| Noubar Afeyan | 20,774,885 | — | Schedule 13D, filed January 13, 2026 |
| Funds affiliated with Flagship Pioneering, Inc. | 17,145,056 | — | Proxy statement (DEF 14A), proxy filed April 30, 2026 |
| Entities affiliated with Fidelity Investments | 6,434,877 | — | Proxy statement (DEF 14A), proxy filed April 30, 2026 |
| Entities affiliated with Biotechnology Value Fund | 6,092,341 | — | Proxy statement (DEF 14A), proxy filed April 30, 2026 |
| FMR (Fidelity) | 6,047,198 | — | Form 13F, quarter ended March 31, 2026 |
| BVF PARTNERS L P/IL | 5,866,613 | — | Schedule 13G, filed May 15, 2026 |
| Deerfield Mgmt, L.P. | 5,139,523 | — | Schedule 13G, filed May 14, 2026 |
| Eli Lilly and Company | 4,000,000 | — | Proxy statement (DEF 14A), proxy filed April 30, 2026 |
| Deerfield Partners LP | 3,680,451 | — | Proxy statement (DEF 14A), proxy filed April 30, 2026 |
| Cigall Kadoch, Ph.D. | 3,652,909 | — | Proxy statement (DEF 14A), proxy filed April 30, 2026 |
Percentages above are of 58,713,922 shares outstanding, as reported by Foghorn Therapeutics Inc. on its Form 10-Q dated April 30, 2026 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
At Foghorn Therapeutics Inc.'s shareholder meeting held June 24, 2026, in the 2025-2026 proxy season, 116 asset managers reported votes on at least one item in their SEC Form N-PX filings, covering 888 separate fund positions. Their filings are grouped here into 6 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. Foghorn Therapeutics Inc.'s own Form 8-K tally for this meeting is published below, but no row in it could be matched to the most widely held item, so this page states no certified outcome for that item. On that item — TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF FOGHORN'S NAMED EXECUTIVE OFFICERS. — the reporting funds and managers cast 98% of the shares they voted in favour (FOR divided by FOR plus AGAINST plus WITHHELD; abstained and unvoted shares are excluded because neither took a side). Fund and manager reports are combined in it and may count the same shares twice: it adds fund reports to institutional-manager reports, which can cover the same shares. It is not the company's certified result.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Foghorn Therapeutics Inc.’s 10-Q dated April 30, 2026. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.
Foghorn Therapeutics Inc. proxy season coverage: 2025-2026 (this page).
Proxy Votes Now, “Foghorn Therapeutics (FHTX) 2026 Annual Meeting: Vote Results”, https://proxyvotesnow.com/company/foghorn-therapeutics-inc/2026 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.